A McMaster researcher will head a new Canadian network which has been formed to find innovative ways to prevent stroke.
Develop actionable strategies to reduce the incidence of embolic stroke in Canada by 10% within ten years.
The LAAOS III trial is randomly assigning patients with AF undergoing heart surgery for other reasons to have the left atrial appendage removed or not.
A key early success of C-SPIN has been the rapid and collegial integration of members from different groups within the multidisciplinary research network.
For every minute delay in treating a stroke, the average patient loses 1.9 million brain cells, 13.8 billion synapses, and 12 km of axonal fibres (Saver, 2006).
C-SPIN has undertaken randomized trials designed to find new ways to prevent embolic stroke and to formally evaluate new strategies to increase the uptake of new and existing stroke prevention interventions at the community level. The projects address different, yet complementary ways to prevent embolic stroke. These trials will also improve our fundamental understanding of the multiple causes of embolic stroke; especially of the relationship between AF and stroke.